PATENT CLAIM ANALYSIS

Application Number: 15977640
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "001300"]

Abstract:
The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.

Claim (Index 36):
The conjugate of  claim 32 , or a pharmaceutically acceptable salt thereof, wherein the linker further comprises a cyclic structure selected from the group consisting of a cyclic ether, a cyclic amine, a heterocycle, and a heteroarylene.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 93.0
- Lexical Diversity: 1.72727
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14443212', '15245505', '12530952', '15606913', '15959110']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.733015814565401
- 35 USC 102 Novelty (BERT): 0.5541191172582457
- Combined Prediction Score: 0.7151261448346855
- Mean Citation Score: 323.20999
- Max Citation Score: 418.15216
- Similarity Product: 296.37127925481786

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test